CD22 loss enhances phagocytosis in myeloid cells and ameliorates Alzheimer’s disease-like pathology in mice

Abstract CD22, an inhibitory receptor canonically expressed in B cells, is also present in microglia of the murine central nervous system. In the human brain, CD22 was predominantly found in oligodendrocytes, but also in a subset of brain-resident myeloid cells from patients with Alzheimer’s disease, while it is also expressed in peripheral monocytes and differentiated THP-1 cells. CD22 has been implicated as a negative regulator of microglial phagocytosis. Here, we demonstrate that genetic ablation of CD22 in APPPS1 transgenic mice, a widely used murine model of Alzheimer’s disease-like pathology, attenuates amyloid-β pathology and protects parvalbumin-positive interneurons in an age-dependent manner. Mechanistically, microglia and differentiated THP-1 cells lacking CD22 exhibit enhanced activation and phagocytosis following stimulation of the pattern-recognition receptor CLEC7A, mediated by increased SYK signaling. Conversely, activation of CD22 with the agonistic antibody epratuzumab suppresses activation of differentiated THP-1 cells. Our findings identify a CLEC7A-CD22-SYK signaling axis in both human and murine myeloid cells, in which CD22 functions as an inhibitory regulator of CLEC7A-mediated cell activation.

Authors

Institutions

Publication Details

Journal
The EMBO Journal
Published
2026-11-15
DOI
https://doi.org/10.1038/s44318-026-00961-3
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CD22 loss enhances phagocytosis in myeloid cells and ameliorates Alzheimer’s disease-like pathology in mice

Marina Jendrach, Urszula Świerczek, Christian Madry, Vadim M. Farztdinov et al.
The EMBO Journal
Neuroinflammation and Neurodegeneration Mechanisms
article

CD22 loss enhances phagocytosis in myeloid cells and ameliorates Alzheimer’s disease-like pathology in mice

Marina Jendrach, Urszula Świerczek, Christian Madry, Vadim M. Farztdinov, Niclas Gimber, Jan Schmoranzer, Michael Mülleder, Tyler Pugeda, Markus Ralser, Frank L. Heppner, Jan Robin Licha, Veroniqué Tschui, Katharina Janvier, Luna Soso Zdravkovic, Annika Hager
article en

Abstract

Abstract CD22, an inhibitory receptor canonically expressed in B cells, is also present in microglia of the murine central nervous system. In the human brain, CD22 was predominantly found in oligodendrocytes, but also in a subset of brain-resident myeloid cells from patients with Alzheimer’s disease, while it is also expressed in peripheral monocytes and differentiated THP-1 cells. CD22 has been implicated as a negative regulator of microglial phagocytosis. Here, we demonstrate that genetic ablation of CD22 in APPPS1 transgenic mice, a widely used murine model of Alzheimer’s disease-like pathology, attenuates amyloid-β pathology and protects parvalbumin-positive interneurons in an age-dependent manner. Mechanistically, microglia and differentiated THP-1 cells lacking CD22 exhibit enhanced activation and phagocytosis following stimulation of the pattern-recognition receptor CLEC7A, mediated by increased SYK signaling. Conversely, activation of CD22 with the agonistic antibody epratuzumab suppresses activation of differentiated THP-1 cells. Our findings identify a CLEC7A-CD22-SYK signaling axis in both human and murine myeloid cells, in which CD22 functions as an inhibitory regulator of CLEC7A-mediated cell activation.

The EMBO Journal
German Center for Neurodegenerative Diseases (DE), Humboldt-Universität zu Berlin (DE), German Rheumatism Research Centre (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon